18 Results

People

  1. Stein
    Stein
  2. Tallman
    Tallman
  3. Bewersdorf
    Bewersdorf
  4. Goldberg
    Goldberg
  5. Park
    Park
  6. Abdel-Wahab
    Abdel-Wahab
  7. Andreeff
    Andreeff
  8. Arcila
    Arcila
  9. Aypar
    Aypar
  10. Ball
    Ball

Groups

  1. Adult Leukemia (18)
  2. Center for Hematologic Malignancies (18)
  3. Department of Medicine (18)
  4. Hematologic Malignancies, Division of (18)
  5. GSK Faculty (3)
  6. Molecular Pharmacology and Chemistry Program Faculty (3)
  7. Sloan Kettering Institute Faculty (3)
  8. GME, Medicine (2)
  9. Graduate Medical Education (2)
  10. Hematologic Malignancies Research (2)
  1. "human"
  2. "Adult Leukemia"
  3. "Journal article"
  4. "Leukemia and Lymphoma"
Formats
  1. Journal Article (18)
Groups
  1. Adult Leukemia (18)
  2. Center for Hematologic Malignancies (18)
  3. Department of Medicine (18)
  4. Hematologic Malignancies, Division of (18)
  5. GSK Faculty (3)
  6. Molecular Pharmacology and Chemistry Program Faculty (3)

More Groups

People
  1. Eytan Stein (4)
  2. Jae Park (3)
  3. Martin Tallman (3)
  4. Aaron Goldberg (2)
  5. Anthony Mato (2)
  6. Jan Bewersdorf (2)

More People

Years
  1. 2024 (1)
  2. 2023 (4)
  3. 2022 (2)
  4. 2020 (3)
  5. 2019 (1)
  6. 2018 (1)

More Years

Publications
  1. Leukemia and Lymphoma (18)
Publishers
  1. Taylor & Francis Group (18)

Results (18)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Results from phase 1 of the MANIFEST clinical trial to evaluate the safety and tolerability of pelabresib in patients with myeloid malignancies
    Journal Article

    Stein, E. M.; Fathi, A. T.; Harb, W. A.; Colak, G.; Fusco, A.; Mangan, J. K.
    Leukemia and Lymphoma (2024)

    Fulltext@MSK | Save
  • Use of tamibarotene, a potent and selective RARĪ± agonist, in combination with azacitidine in patients with relapsed and refractory AML with RARA gene overexpression
    Journal Article

    Stein, E. M.; de Botton, S.; Cluzeau, T.; Pigneux, A.; Liesveld, J. L.; Cook, R. J.; Rousselot, P.; Rizzieri, D. A.; Braun, T.; Roboz, G. J.; more...
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • Cost-effectiveness of azacitidine and ivosidenib in newly diagnosed older, intensive chemotherapy-ineligible patients with IDH1-mutant acute myeloid leukemia
    Journal Article

    Bewersdorf, J. P.; Patel, K. K.; Goshua, G.; Shallis, R. M.; Podoltsev, N. A.; Stahl, M.; Stein, E. M.; Huntington, S. F.; Zeidan, A. M.
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • Time to second treatment can be used to predict overall survival in chronic lymphocytic leukemia: Identifying risk factors to help guide treatment selection
    Journal Article

    Bantilan, K. S.; Kay, N. E.; Parikh, S. A.; Rabe, K. G.; Call, T. G.; Leis, J. F.; Ding, W.; Slager, S. L.; Soumerai, J. D.; Roeker, L. E.; more...
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • Venetoclax-based salvage therapy in patients with relapsed/refractory acute myeloid leukemia previously treated with FLT3 or IDH1/2 inhibitors
    Journal Article

    Bewersdorf, J. P.; Shallis, R. M.; Derkach, A.; Goldberg, A. D.; Stein, A.; Stein, E. M.; Marcucci, G.; Zeidan, A. M.; Shimony, S.; DeAngelo, D. J.; more...
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • A phase 1b study of atezolizumab in combination with guadecitabine for the treatment of acute myeloid leukemia
    Journal Article

    Prebet, T.; Goldberg, A. D.; Jurcic, J. G.; Khaled, S.; Dail, M.; Feng, Y.; Green, C.; Li, C.; Ma, C.; Medeiros, B. C.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Treatment outcomes for patients with myelodysplastic syndrome/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis
    Journal Article

    Komrokji, R.; Melody, M.; al Ali, N.; Chan, O.; Klimek, V.; Ball, B. J.; Sekeres, M. A.; Lucas, G.; Maciejewski, J. P.; Sallman, D. A.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • A novel PrECOG (PrE0901) dose-escalation trial using eltrombopag: enhanced platelet recovery during consolidation therapy in acute myeloid leukemia
    Journal Article

    Strickland, S. A.; Wang, X. V.; Cerny, J.; Rowe, J. M.; Rybka, W.; Tallman, M. S.; Litzow, M.; Lazarus, H. M.
    Leukemia and Lymphoma (2020)

    Fulltext@MSK | Save
  • Cardiovascular mortality among chronic myeloid leukemia patients in the pre-tyrosine kinase inhibitor (TKI) and TKI eras: A surveillance, epidemiology and end results (SEER) analysis
    Journal Article

    Wang, Q.; Jiang, C.; Zhang, Y.; Zhang, Y.; Yue, B.; Zheng-Lin, B.; Zhao, Y.; Mauro, M. J.
    Leukemia and Lymphoma (2020)

    Fulltext@MSK | Save
  • Clonally-related CD5+ CLL/SLL and CD10+ high grade B-cell lymphoma suggests common neoplastic progenitor with branched disease evolution, with therapeutic implications
    Journal Article

    Kumar, P.; Uppal, M.; Xiao, W.; Dogan, A.; Roshal, M.; Gao, Q.; Aypar, U.; Zhang, Y.; Arcila, M. E.; Moung, C.; more...
    Leukemia and Lymphoma (2020)

    Fulltext@MSK | Save